DRW is committed to tackling some of the world's most serious infectious diseases by making widely available breakthrough point-of care diagnostics developed in the Diagnostic Development Unit of Cambridge University.
Its signal amplification technologies offer rapid and reliable tests for resource-limited settings. DRW is currently focused on providing rapid Early Infant Diagnosis (EID) as well as Viral Load (VL) measurement for those living with HIV, thereby enabling test-and-treat facility in even the most challenging and remote environments.
IMPROVING PATIENT OUTCOMES
PHOTO: Jessica Scranton